R
Richard W. Nesto
Researcher at Lahey Hospital & Medical Center
Publications - 186
Citations - 16288
Richard W. Nesto is an academic researcher from Lahey Hospital & Medical Center. The author has contributed to research in topics: Coronary artery disease & Diabetes mellitus. The author has an hindex of 56, co-authored 186 publications receiving 15630 citations. Previous affiliations of Richard W. Nesto include Tufts University & Mercy Hospital and Medical Center.
Papers
More filters
Journal ArticleDOI
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus A scientific statement from the American Heart Association and the American Diabetes Association
John B. Buse,Henry N. Ginsberg,George L. Bakris,Nathaniel G. Clark,Fernando Costa,Robert H. Eckel,Vivian Fonseca,Hertzel C. Gerstein,Scott M. Grundy,Richard W. Nesto,Michael Pignone,Jorge Plutzky,Daniel Porte,Rita F. Redberg,Kimberly F. Stitzel,Neil J. Stone +15 more
TL;DR: This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.
Journal ArticleDOI
Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure A Consensus Statement From the American Heart Association and American Diabetes Association
Richard W. Nesto,David S.H. Bell,Robert O. Bonow,Vivian Fonseca,Scott M. Grundy,Edward S. Horton,Martin Le Winter,Daniel Porte,Clay F. Semenkovich,Sidney C. Smith,Lawrence H. Young,Richard Kahn +11 more
TL;DR: Because people with diabetes are at increased risk for CVD and many have preexisting heart disease, the edema that sometimes accompanies the use of a TZD can be cause for concern, as it may be a harbinger or sign of congestive heart failure (CHF).
Journal ArticleDOI
Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial
Steven E. Nissen,Stephen J. Nicholls,Kathy Wolski,Richard W. Nesto,Stuart Kupfer,Alfonso Perez,Horacio Jure,Robert De Larochellière,Cezar Staniloae,Kreton Mavromatis,Jacqueline Saw,Bo Hu,A. Michael Lincoff,E. Murat Tuzcu +13 more
TL;DR: In patients with type 2 diabetes and coronary artery disease, treatment with pioglitazone resulted in a significantly lower rate of progression of coronary atherosclerosis compared with glimepiride.
Journal ArticleDOI
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus A Scientific Statement From the American Heart Association and the American Diabetes Association
John B. Buse,Henry N. Ginsberg,George L. Bakris,Nathaniel G. Clark,Fernando Costa,Robert H. Eckel,Vivian Fonseca,Hertzel C. Gerstein,Scott M. Grundy,Richard W. Nesto,Michael Pignone,Jorge Plutzky,Daniel Porte,Rita F. Redberg,Kimberly F. Stitzel,Neil J. Stone +15 more
TL;DR: This statement will attempt to harmonize the recommendations of both organizations where possible but will recognize areas in which AHA and ADA recommendations differ.
Journal ArticleDOI
Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
Richard W. Nesto,David S.H. Bell,Robert O. Bonow,Vivian Fonseca,Scott M. Grundy,Edward S. Horton,Martin Le Winter,Daniel Porte,Clay F. Semenkovich,Sidney C. Smith,Lawrence H. Young,Richard Kahn +11 more
TL;DR: Beneficial effects of TZDs on glycemia and cardiovascular risk factors have made them attractive agents in patients with type 2 diabetes who are at high risk for CVD, there is a growing recognition, however, that edema can occur in patients treated with either drug.